NEW YORK (GenomeWeb) – Intrexon today priced a public offering of almost 4.9 million shares of its common stock aimed at raising $200 million in gross proceeds. 

The Germantown, Maryland-based synthetic biology firm is offering 4,878,049 shares of its stock at $41 per share. Proceeds from the offering will go toward general corporate purposes and strategic acquisitions or investments, it said. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.